MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
ENOV stock logo

ENOV

Enovis Corporation

$22.64
-0.73
 (-3.12%)
[ms_data_label text=’Delayed data’]
Exchange:  NYSE
Market Cap:  1.296B
Shares Outstanding:  7.295M
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Industrials
Industry:  Industrial – Machinery
   
CEO:  Damien McDonald
Full Time Employees:  7367
Address: 
2711 Centerville Road
Wilmington
DE
19808
US
Website:  https://www.enovis.com
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.

Click to read more…

Revenue Segmentation

MARKETSnap
MARKETSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2025/05/11 — Q1 quarter 2025

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue1,707,1972,107,6232,248,049
Gross Profit990,7791,180,7561,345,260
EBITDA169,730-481,028-830,217
Operating Income-65,709-775,719-1,181,711
Net Income-33,261-825,494-1,184,440

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets4,509,3344,718,7773,834,737
Total Liabilities1,088,6332,154,4482,342,835
Total Stockholders Equity3,418,3922,562,2621,489,645
Total Debt536,4161,404,30193,000
Cash and Cash Equivalents36,19148,16736,389

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow134,988113,504217,293
Capital Expenditure-122,223-180,714-197,376
Free Cash Flow12,765-67,21019,917
Net Income-33,261-824,815-1,183,620
Net Change in Cash20,5373,335-11,778

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2028Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)2,576,447.312Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)2,579,902.437Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)2,578,174.875Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)-115,641.311Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)-115,486.439Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)-115,563.875Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)248,442.855Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)253,566.629Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)251,004.742Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)1,220,918.838Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)1,222,556.142Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)1,221,737.490Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)4.420Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)4.460Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)4.370Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)2Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)1Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
2.108B  ?P/S
 (TTM)
: 
0.6
?Net Income
 (TTM)
: 
-825494000  ?P/E
 (TTM)
: 
-1.13
?Enterprise Value
 (TTM)
: 
2.697B  ?EV/FCF
 (TTM)
: 
135.39
?Dividend Yield
 (TTM)
: 
0  ?Payout Ratio
 (TTM)
: 
0
?ROE
 (TTM)
: 
-0.54  ?ROIC
 (TTM)
: 
-0.36
?Net Debt
 (TTM)
: 
1.356B  ?Debt/Equity
 (TTM)
: 
0.93
?P/B
 (TTM)
: 
0.9  ?Current Ratio
 (TTM)
: 
2.02

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
6.32Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate ENOV Intrinsic Value

Common questions about ENOV valuation

Is Enovis Corporation (ENOV) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Enovis Corporation (ENOV) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is ENOV a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether ENOV trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is ENOV’s P/E ratio?

You can see ENOV’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for ENOV?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is ENOV a good long-term investment?

Whether ENOV fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

ENOV

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

[ms_data_label text="Daily snapshot"]

-3.12
MARKETSnap

Trading Metrics:

[ms_session_rows_unavailable]
Open: [ms_cell_or_dash table='trading_quote' column='open']   Previous Close: [ms_cell_or_dash table='trading_quote' column='previousClose']
Day Low: [ms_cell_or_dash table='trading_quote' column='dayLow']   Day High: [ms_cell_or_dash table='trading_quote' column='dayHigh']
Year Low: 21   Year High: 37.85
Price Avg 50: 22.99   Price Avg 200: 28
Volume: 508335   Average Volume: 989495

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

Enovis to Host First Quarter 2026 Results Conference Call on May 7th
10-04-2026 08:00
Enovis to Host First Quarter 2026 Results Conference Call on May 7th
American Century Companies Inc. Sells 258,262 Shares of Enovis Corporation $ENOV
02-03-2026 03:08
American Century Companies Inc. Sells 258,262 Shares of Enovis Corporation $ENOV
One Fund Bet $5 Million on Enovis Stock Last Quarter. Shares Surged 14% Post-Earnings
26-02-2026 16:40
One Fund Bet $5 Million on Enovis Stock Last Quarter. Shares Surged 14% Post-Earnings
Enovis (ENOV) Q4 Earnings Beat Estimates
26-02-2026 09:15
Enovis (ENOV) Q4 Earnings Beat Estimates
Enovis to Host Fourth Quarter and Full Year 2025 Results Conference Call on February 26th
23-01-2026 08:30
Enovis to Host Fourth Quarter and Full Year 2025 Results Conference Call on February 26th
Enovis Appoints Oliver Engert as Chief Administrative Officer
05-01-2026 16:15
Enovis Appoints Oliver Engert as Chief Administrative Officer

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States
  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read